Long-Term Safety of Dapagliflozin in Older Patients with Type 2 Diabetes Mellitus: A Pooled Analysis of Phase IIb/III Studies

OBJECTIVE: To evaluate the 104-week safety of dapagliflozin in older patients with type 2 diabetes mellitus. METHODS: Pooled analysis assessing general safety (nine phase III studies ≤104 weeks) and cardiovascular safety (21 phase IIb/III studies ≤208 weeks) by age (<65; ≥65; ≥75 years). Patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Fioretto, Paola, Mansfield, Traci A., Ptaszynska, Agata, Yavin, Yshai, Johnsson, Eva, Parikh, Shamik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937081/
https://www.ncbi.nlm.nih.gov/pubmed/27357173
http://dx.doi.org/10.1007/s40266-016-0382-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937081/
https://www.ncbi.nlm.nih.gov/pubmed/27357173
http://dx.doi.org/10.1007/s40266-016-0382-1

Ejemplares similares